CompletedPhase 3NCT02333305

Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10

Studying Ataxia-oculomotor apraxia type 1

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Assistance Publique - Hôpitaux de Paris
Principal Investigator: Perrine Charles, MD, PhD
Assitance Publique - Hopitaux de Paris
Intervention: CoQ10(dietary_supplement)
Enrollment: 19 enrolled
Eligibility: 18 years · All sexes
Timeline: 2013 – 2017

Study locations (1)

ICM Institute, Paris, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02333305 on ClinicalTrials.gov

← Back to all trials